ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01554254
Recruitment Status : Withdrawn (Lack of enrollment)
First Posted : March 14, 2012
Last Update Posted : August 31, 2016
Sponsor:
Information provided by (Responsible Party):
Tarix Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : December 2013
  Study Completion Date : No date given